Protozoa and Worms

Published on 05/03/2015 by admin

Filed under Dermatology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 3004 times

[level-membership-for-dermatology-category]70

Protozoa and Worms

Leishmaniasis

• Three major forms: (1) cutaneous (Fig. 70.1); (2) mucocutaneous (Fig. 70.2); and (3) visceral (e.g. liver, spleen).

• Caused by more than 15 different species of Leishmania (Table 70.1).

• Vector = sandfly (Phlebotomus and Lutzomyia spp.) (Fig. 70.3).

• Disease seen worldwide but endemic in areas of Asia, Africa, Latin America, and the Mediterranean basin (Fig. 70.4).

• Cutaneous disease affects skin only and is commonly a papule that expands and ulcerates (Fig. 70.5); pattern may be sporotrichoid (Fig. 70.6); lesion(s) may heal spontaneously (Fig. 70.7).

• Mucocutaneous form, often due to Leishmania brasiliensis, involves mucosal (e.g. nose, lips, oropharynx) sites as well as the skin.

• Visceral leishmaniasis (kala-azar) affects the bone marrow, spleen, and liver and is commonly due to Leishmania donovani; symptoms include fever, cough, lymphadeno­pathy, and hepatosplenomegaly; post-kala-azar dermal leishmaniasis may follow treatment.

• Rx: for an isolated lesion, conservative therapy (e.g. observation, heat, cryotherapy) or topical paromycin can be used; for more extensive disease, IV or IM pentavalent antimony (sodium stibogluconate, meglumine antimonate), oral miltefosine.

• For assistance in diagnosis and treatment, helpful sources of information include the Centers for Disease Control and World Health Organization.

[/level-membership-for-dermatology-category][not-level-membership-for-dermatology-category]70

Protozoa and Worms

Leishmaniasis

• Three major forms: (1) cutaneous (Fig. 70.1); (2) mucocutaneous (Fig. 70.2); and (3) visceral (e.g. liver, spleen).

• Caused by more than 15 different species of Leishmania (Table 70.1).

• Vector = sandfly (Phlebotomus and Lutzomyia spp.) (Fig. 70.3).

• Disease seen worldwide but endemic in areas of Asia, Africa, Latin America, and the Mediterranean basin (Fig. 70.4).

• Cutaneous disease affects skin only and is commonly a papule that expands and ulcerates (Fig. 70.5); pattern may be sporotrichoid (Fig. 70.6); lesion(s) may heal spontaneously (Fig. 70.7).

• Mucocutaneous form, often due to Leishmania brasiliensis, involves mucosal (e.g. nose, lips, oropharynx) sites as well as the skin.

• Visceral leishmaniasis (kala-azar) affects the bone marrow, spleen, and liver and is commonly due to Leishmania donovani; symptoms include fever, cough, lymphadeno­pathy, and hepatosplenomegaly; post-kala-azar dermal leishmaniasis may follow treatment.

• Rx: for an isolated lesion, conservative therapy (e.g. observation, heat, cryotherapy) or topical paromycin can be used; for more extensive disease, IV or IM pentavalent antimony (sodium stibogluconate, meglumine antimonate), oral miltefosine.

• For assistance in diagnosis and treatment, helpful sources of information include the Centers for Disease Control and World Health Organization.